$17.71
0.492.85%
Last update: 12:33 PM
15 minutes delayed
Phathom Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Phathom Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-1.25 | $-1.38 | 9.42 % |
Dec 2023 | 2024-03-07 | $-1.39 | $-1.08 | -28.7 % |
Sep 2023 | 2023-11-09 | $-0.76 | $-0.89 | 14.6 % |
Jun 2023 | 2023-08-10 | $-0.84 | $-1.00 | 16.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $7.32M | $5.81M | 26.1 % |
Mar 2024 | 2024-05-09 | $1.91M | $2.05M | -6.73 % |
Dec 2023 | 2024-03-07 | $682.00K | $410.00K | 66.3 % |
Mar 2022 | 2022-05-10 | $0 | $210.00K | -100.0 % |
Phathom Pharmaceuticals (PHAT) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-1.25, which beat the estimate of $-1.38.
The Actual Revenue was $7.3M, which beat the estimate of $5.8M.
Browse earnings estimates, EPS, and revenue on all stocks.